Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

New JA-14.50 Rotors from Beckman Coulter Life Sciences

Published: Friday, March 14, 2014
Last Updated: Friday, March 14, 2014
Bookmark and Share
High performance unit supports full range of common tubes.

Designed for applications that use common, disposable conical tubes, JA-14.50 rotors from Beckman Coulter Life Sciences extend the applications and flexibility of the company’s Avanti centrifuge series, and can be used in Avanti J-26S, J-30I and J-E centrifuges.

While greater capacity results in higher throughput, the rotors maintain the precision performance offered by products in the Avanti line and are the only high-performance rotors capable of spinning 50, 15, 5 and 1.5mL conical tubes, and 50, 15 and 10 mL round bottom tubes and bottles at their maximum speeds.

Delivering a top speed of 14,000 rpm and rcf of 35,000 x g, JA-14.50 rotors hold up to 16 x 50 mL conical tubes and maximize the number of 50mL conical tubes that can be processed in a single run.

The fixed-angle rotor is intended for general pelleting of cells, bacteria and food products; separating proteins, viruses and sub cellular fractions; running concentrators and columns; and for phase separation and binding studies.

Avanti centrifuges are available with a selection of BioCertified fixed-angle and swinging-bucket rotors, ranging in capacity from 360 mL to 6 L and all independently certified to contain liquids and aerosols. A BioCertified dual-locking lid configuration, for workflows that include biohazardous samples, maintains biocontainment when removing the rotor from the centrifuge and transporting it to a containment hood. Rotors are also available in a standard single-locking lid configuration.

Avanti rotors, including the new JA-14.50 rotor, have a unique ID that is tracked using magnetic sensors; the centrifugation system uses Dynamic Rotor Inertia Check and the ID for Automatic Rotor Identification and to ensure that no individual rotor exceeds the maximum speed permitted.

“We’re proud to introduce the JA-14.50 rotor - it improves workflows, saving scientists’ time, and is useful across a diverse array of applications where a variety of conical tube sizes are commonly used,” said Randall Lockner, marketing manager at Beckman Coulter Life Sciences. “Users can rely upon the quality, performance and efficiency for which Beckman Coulter centrifugation products are known.”

In addition to compatibility with current models, JA-14.50 rotors can be used in installed Avanti J-20 and J-25 centrifuges.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Beckman Coulter Diagnostics Obtains CE Marks for DxN VERIS HCV Assay
Growing menu of assays allow for rapid turnaround of results with a more efficient workflow.
Thursday, June 11, 2015
FDA Clears Beckman's AQUIOS CL Flow Cytometer For Clinical Labs
The company's new, automated AQUIOS CL Flow Cytometer has received clearance from the U.S. Food and Drug Administration (FDA) for routine applications in the clinical laboratory.
Wednesday, May 06, 2015
Beckman Coulter Diagnostics and Seegene Supply Agreement
Supply agreement announced for multiplex reagents for VERIS molecular diagnostics system.
Monday, November 17, 2014
Beckman Coulter Obtains CE Mark for VERIS MDx System
Beckman Coulter Diagnostics has obtained CE Mark for the VERIS MDx System* and VERIS human Cytomegalovirus (CMV) assay*.
Monday, May 12, 2014
Beckman To Acquire Cytometer Developer Xitogen
Acquisition will broaden product offering, providing an Asian operations centre.
Wednesday, April 23, 2014
New Beckman Coulter Assay Receives FDA Clearance and CE Mark
Assay is first to standardize to World Health Organization’s 5th International Standard for chorionic gonadotropin.
Friday, January 17, 2014
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos